CHL1 Gene Differentiates Hurthle Cell Carcinoma From Hurthle Cell Benign Disease

Poster: "EANM 18 / EP-0666 / CHL1 Gene Differentiates Hurthle Cell Carcinoma From Hurthle Cell Benign Disease" by: "W. M. Li1, S. Xia2, A. Aronova3, I. M. Min3, A. Verma4, T. Scognamiglio3, K. D. Gray3, T. M. Ullmann3, H. Liang3, M. D. Moore3, O. Elemento4, R. Zarnegar3, T. J. Fahey III3; 1Tianjin Medical University General Hospital, Tianjin, CHINA, 2Rui Jin Hospital Shanghai Jiao Tong University School of Medicine,, Shanghai, CHINA, 3New York Presbyterian Hospital-Weill Cornell Medical College, New York, UNITED STATES OF AMERICA, 4Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medical College, New York, UNITED STATES OF AMERICA"